SCHEMBL7702953

SCHEMBL7702953

CS(=O)(=O)NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(OCc2ccc3ccccc3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.53
CA2 P00918 1/20 0.51
GPR132 Q9UNW8 2/20 0.50
GAA P10253 1/20 0.49
RAB9A P51151 1/20 0.49
BCL2 P10415 1/20 0.48
PTPN2 P17706 1/20 0.47
CDC25B P30305 1/20 0.47
CTSL P07711 1/20 0.47
CTSB P07858 1/20 0.47
CTSS P25774 1/20 0.47
CTSK P43235 1/20 0.47
MAOB P27338 1/20 0.47
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
ACE P12821 4/20 0.46
ADAMTS4 O75173 1/20 0.45
MMP13 P45452 1/20 0.45
CAPN1 P07384 1/20 0.44
ERAP2 Q6P179 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701695 0.90 CA2 (0.52) PTPN1CA2GPR132GAARAB9A
SCHEMBL7420467 0.87 PTPN1 (0.45) PTPN1CA2BCL2PTPN2CDC25B
SCHEMBL7694848 0.87 PTPN1 (0.55) PTPN1CA2GPR132GAARAB9A
SCHEMBL7696969 0.87 PTPN1 (0.56) PTPN1CA2GPR132GAARAB9A
SCHEMBL7701294 0.84 CA2 (0.50) PTPN1CA2GAARAB9ACTSL
SCHEMBL7698087 0.84 CA2 (0.51) PTPN1CA2GAARAB9ACTSL
SCHEMBL7706585 0.81 ALDH1A1 (0.53) CA2GAA
SCHEMBL7678439 0.80 ADAMTS4 (0.48) PTPN1CA2GAABCL2NPC1
SCHEMBL7694857 0.79 CA2 (0.43) CA2CTSLCTSBCTSSCTSK
SCHEMBL7789811 0.77 PIN1 (0.55) PTPN1GPR132PTPN2CDC25BMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed